Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Wnt ligand inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H21FN8 |
InChIKeyYBBUGSYNPXTSGW-UHFFFAOYSA-N |
CAS Registry1481617-15-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 19 Feb 2021 | |
Idiopathic Pulmonary Fibrosis | Preclinical | US | 19 Feb 2021 | |
Neoplasms | Preclinical | US | 19 Feb 2021 | |
Osteoarthritis | Preclinical | US | 19 Feb 2021 |